Market Place
Sourcing Support
Akorn’s bankruptcy, recalls bring a drug to treat lead poisoning into shortage
27 Jul 2023 //
ENDPTS
Akorn`s Generic Ciprofloxacin, Dexamethasone Receives Approval in the U.S.
09 Jun 2023 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Akorn Issues Voluntary Nationwide Recall of Various Human & Animal Drug Products
03 May 2023 //
BUSINESSWIRE
Thea Pharma Statement Related to Akorn`s Recall of Various Human & Animal Drug
28 Apr 2023 //
PR NEWSWIRE
After Akorn`s site closures in the US, albuterol remains in shortage
31 Mar 2023 //
ENDPTS
Akorn`s closure pressures already strained supplies of albuterol
10 Mar 2023 //
FIERCE PHARMA
Akorn Pharmaceuticals files for bankruptcy, closes facilities and will liquidate
02 Mar 2023 //
ENDPTS
Bankrupt Akorn Pharma calls it quits and closes all US sites
23 Feb 2023 //
FIERCE PHARMA
Generic drugmaker Akorn shutters Illinois plant, lays off 400 employees
23 Feb 2023 //
ENDPTS
Enforcement Report - Week of February 15, 2023
15 Feb 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Akorn Introduces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
27 Oct 2022 //
PRNEWSWIRE
Enforcement Report - Week of October 5, 2022
05 Oct 2022 //
FDA
Pharmaceutical Company Akorn Agrees to Pay $7.9 Million
16 Sep 2022 //
JUSTICE
Akorn to pay almost $8M after selling OTC drugs under obsolete prescription
15 Sep 2022 //
ENDPTS
Enforcement Report - Week of September 14, 2022
14 Sep 2022 //
FDA
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
16 Aug 2022 //
PRNEWSWIRE
Akorn`s Generic Cetrorelix Acetate Receives Approval in the U.S.
12 Aug 2022 //
FDA
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Enforcement Report - Week of May 11, 2022
11 May 2022 //
PRESS RELEASE
Enforcement Report - Week of March 30, 2022
30 Mar 2022 //
FDA
Théa to Acquire Branded Ophthalmic Products from Akorn
28 Jan 2022 //
BUSINESSWIRE
Enforcement Report - Week of January 19, 2022
19 Jan 2022 //
FDA
Enforcement Report - Week of October 13, 2021
13 Oct 2021 //
FDA
Enforcement Report - Week of September 22, 2021
22 Sep 2021 //
FDA
Enforcement Report - Week of September 8, 2021
08 Sep 2021 //
FDA
Prestige to acquire Akorn’s consumer product portfolio for $230m
28 May 2021 //
PHARMACEUTICAL-TECHNOLOGY
Akorn Announces Agreement to Sell its Consumer Health Business
27 May 2021 //
PRNEWSWIRE
Enforcement Report - Week of March 24, 2021
24 Mar 2021 //
FDA
Akorn Announces Review of Strategic Alternatives for the Akorn
26 Feb 2021 //
PRNEWSWIRE
Akorn Inc`s Generic Loteprednol Etabonate Receives Approval In US
16 Feb 2021 //
FDA
Akorn Inc`s Generic Loteprednol Etabonate Receives Approval In US
13 Feb 2021 //
FDA
Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%
11 Feb 2021 //
PRNEWSWIRE
Akorn Inc`s Generic Diclofenac Sodium Receives Approval In US
30 Jan 2021 //
FDA
Enforcement Report - Week of January 20, 2021
20 Jan 2021 //
FDA
Enforcement Report for Week of October 7, 2020
07 Oct 2020 //
FDA
Akorn finalizes sale to lenders and exits Chapter 11 protection
02 Oct 2020 //
SEEKINGALFA
Akorn Inc`s Generic Timolol Maleate Receives Approval In US
15 Sep 2020 //
FDA
Life sciences industry dodges unemployment woes in U.S.
17 Aug 2020 //
FIERCE PHARMA
Enforcement Report - Week of July 22, 2020
22 Jul 2020 //
FDA
Enforcement Report - Week of June 17, 2020
17 Jun 2020 //
FDA
In bid to sell to lenders, embattled Akorn files for bankruptcy
22 May 2020 //
FIERCE PHARMA
Once valued at $4B, an embattled Akorn — nursing a market cap of roughly $37M
21 May 2020 //
ENDPTS
Akorn Files Chapter 11 After Failure to Be Acquired
20 May 2020 //
THESTREET
Midazolam Injection, USP -Drug shortage
10 Apr 2020 //
FDA
Enforcement Report - Week of April 8, 2020
08 Apr 2020 //
FDA
Flexion secures China deal for osteoarthritis drug; Struggling
01 Apr 2020 //
ENDPTS
Enforcement Report - Week of March 4, 2020
04 Mar 2020 //
FDA
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Akorn Announces New Extension of Standstill with Lenders
12 Feb 2020 //
PR NEWSWIRE
Akorn and lenders negotiate its future again
12 Feb 2020 //
FIERCE PHARMA
Akorn Continues Negotiations with Lenders
10 Feb 2020 //
PR NEWSWIRE
Enforcement Report - Week of January 8, 2020
08 Jan 2020 //
FDA
Enforcement Report - Week of October 9, 2019
09 Oct 2019 //
FDA
Enforcement Report - Week of October 2, 2019
02 Oct 2019 //
FDA
Enforcement Report - Week of September 4, 2019
04 Sep 2019 //
FDA
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
26 Aug 2019 //
GLOBENEWSWIRE
